首页 > 产品中心 > 抗体 > 一抗

Anti-Human HIF-1 alpha/HIF1A Recombinant Nanobody (SAA1239) (HS858023)

价格: --
规格:
  • 50ug
  • 100ug
  • 1mg
数量:
  • 概述

  • 图片

  • 参考文献

  • 产品说明书

概述
货号HS858023
品牌abinScience
描述
Anti-Human HIF1A Nanobody (SAA1239) [SAA1239] (HS858023) is a alpaca monoclonal antibody detecting HIF1A in ELISA, WB. Suitable for Human.
种属反应性Human
应用ELISA, WB
宿主Alpaca
克隆类型Monoclonal
同种型VHH-8His-Cys-tag
克隆号SAA1239
靶标HIF1A, MOP1, bHLHe78, Basic-helix-loop-helix-PAS protein MOP1, HIF-1-alpha, BHLHE78, Member of PAS protein 1, Hypoxia-inducible factor 1-alpha, ARNT-interacting protein, PAS domain-containing protein 8, HIF1-alpha, PASD8, Class E basic helix-loop-helix protein 78
内毒素水平< 10 EU/mg as determined by LAL method.
纯度>95% as determined by SDS-PAGE.
纯化方式Purified by Nickel column.
Accession号Q16665
状态Liquid
保存溶液 0.01M PBS pH 7.4.

Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.

产品使用信息
应用方法 稀释比例
ELISA 1:2000-1:20000
WB 1:500-1:2000
稳定性和存储Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
背景

Hypoxia-inducible factor 1-alpha (HIF1A) is a ~92 kDa protein. Functions as a master transcriptional regulator of the adaptive response to hypoxia. Under hypoxic conditions, activates the transcription of over 40 genes, including erythropoietin, glucose transporters, glycolytic enzymes, vascular endothelial growth factor, HILPDA, and other genes whose protein products increase oxygen delivery or facilitate metabolic adaptation to hypoxia. Plays an essential role in embryonic vascularization, tumor angiogenesis and pathophysiology of ischemic disease. Heterodimerizes with ARNT; heterodimer binds to core DNA sequence 5'-TACGTG-3' within the hypoxia response element (HRE) of target gene promoters. Activation requires recruitment of transcriptional coactivators such as CREBBP and EP300.

1. Jaakkola, P. et al. (2001) Science (New York, N.Y.) 292, 468-72. PMID: 11292861
2. Masson, N. et al. (2001) The EMBO journal 20, 5197-206. PMID: 11566883
3. Bae, SH. et al. (2004) Biochemical and biophysical research communications 324, 394-400. PMID: 15465032
4. Choi, SM. et al. (2006) The Journal of biological chemistry 281, 34056-63. PMID: 16973622
5. Berta, MA. et al. (2007) Biochemical and biophysical research communications 360, 646-52. PMID: 17610843
6. Kim, EJ. et al. (2008) Arteriosclerosis, thrombosis, and vascular biology 28, 1796-802. PMID: 18658046
7. Gimm, T. et al. (2010) FASEB journal : official publication of the Federation of American Societies for Experimental Biology 24, 4443-58. PMID: 20624928
8. Shan, B. et al. (2012) Endocrine-related cancer 19, 13-27. PMID: 22009797
9. Xu, C. et al. (2018) PLoS pathogens 14, e1007259. PMID: 30125331
10. Bhattacharya, S. et al. (1999) Genes & development 13, 64-75. PMID: 9887100
NoteFor research use only.
图片
  • SDS-PAGE

    SDS-PAGE for Anti-Human HIF1A Nanobody (SAA1239)

参考文献
公式
质量 (g) = 浓度 (mol/L) × 体积 (L) × 分子量 (g/mol)
填写 质量、浓度、体积中的任意 2 项 + 分子量,自动计算未知值。
质量
=
浓度
×
体积
分子量 *
g/mol
公式
C₁ × V₁ = C₂ × V₂
填写 4 项中的任意 3 项,自动计算未知值。
母液
C₁ (起始浓度)
×
V₁ (起始体积)
=
工作液
C₂ (终浓度)
×
V₂ (终体积)

相关产品推荐